Daihan Pharmaceutical Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	31,556	33,759	28,426	24,961	22,670	17,381
Depreciation & Amortization	8,166	7,282	8,663	9,208	11,411	11,300
Loss (Gain) From Sale of Assets	-48.97	-58.03	-22.53	9.4	-41.28	-19.72
Loss (Gain) From Sale of Investments	-485.59	-303.6	-288.69	-	-	-
Provision & Write-off of Bad Debts	82.92	17.05	10.8	-33.29	-142.8	-319.09
Other Operating Activities	2,444	2,115	4,194	2,632	7,386	8,587
Change in Accounts Receivable	-1,727	-385.22	437.93	-2,172	-10.94	7,321
Change in Inventory	-7,499	-3,194	1,271	-4,407	2,969	-3,812
Change in Accounts Payable	2,702	526.47	-877.61	2,997	-389.71	-455.66
Change in Other Net Operating Assets	-2,794	-4,115	-2,954	-4,194	-3,234	-6,355
Operating Cash Flow	32,397	35,643	38,860	28,999	40,617	33,627
Operating Cash Flow Growth	-12.46%	-8.28%	34.00%	-28.60%	20.79%	-4.64%
Capital Expenditures	-28,190	-15,801	-21,280	-8,621	-11,850	-5,360
Sale of Property, Plant & Equipment	48.99	58.04	22.53	-	41.66	26.81
Investment in Securities	-23,240	-56,883	3,235	8,635	283.86	-5,595
Other Investing Activities	0	0	25	180	10	-9
Investing Cash Flow	-51,381	-72,626	-17,998	193.48	-11,515	-10,938
Short-Term Debt Repaid	-	-	-2,500	-200	-1,000	-1,300
Long-Term Debt Repaid	-	-38.79	-4,080	-16,817	-4,300	-2,301
Total Debt Repaid	-66.78	-38.79	-6,580	-17,017	-5,300	-3,601
Net Debt Issued (Repaid)	-66.78	-38.79	-6,580	-17,017	-5,300	-3,601
Repurchase of Common Stock	-	-	-	-3,418	-	-
Dividends Paid	-5,195	-4,329	-3,752	-2,108	-2,108	-2,108
Financing Cash Flow	-5,262	-4,368	-10,332	-22,543	-7,408	-5,709
Foreign Exchange Rate Adjustments	970.21	1,152	113.04	441.94	671.96	-418.12
Miscellaneous Cash Flow Adjustments	-	-	-	0	-0	0
Net Cash Flow	-23,275	-40,199	10,644	7,092	22,367	16,562
Free Cash Flow	4,207	19,841	17,580	20,378	28,767	28,267
Free Cash Flow Growth	-73.02%	12.86%	-13.73%	-29.16%	1.77%	57.40%
Free Cash Flow Margin	2.01%	9.72%	8.97%	11.06%	16.78%	17.02%
Free Cash Flow Per Share	715.47	3374.38	2989.79	3405.01	4794.57	4711.20
Cash Interest Paid	3.67	1.81	52.47	582.23	451.55	596.73
Cash Income Tax Paid	7,952	8,028	8,656	8,869	3,247	8,022
Levered Free Cash Flow	-2,136	12,013	13,570	17,249	25,715	23,070
Unlevered Free Cash Flow	-2,133	12,014	13,603	17,620	26,009	23,456
Change in Working Capital	-9,317	-7,168	-2,123	-7,777	-665.87	-3,302

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.